Covidien Successfully Completes Tender Offer for Shares of ev3 Inc.

DUBLIN--(BUSINESS WIRE)--Covidien (NYSE: COV), a leading global provider of healthcare products, today announced the successful completion of its tender offer through its subsidiary, COV Delaware Corporation, to purchase all of the outstanding shares of common stock of ev3 Inc. The tender offer expired at 12:00 midnight ET, at the end of July 9, 2010, and was not extended.

Back to news